Cargando…

Prognostic factors for recurrence in patients with surgically resected non-small cell lung cancer

Detalles Bibliográficos
Autores principales:	Satoh, Hiroaki, Iguchi, Kesato, Nakamura, Ryota
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933354/ https://www.ncbi.nlm.nih.gov/pubmed/36816388 http://dx.doi.org/10.5114/wo.2023.124754

Ejemplares similares

Surgical treatment of pulmonary bullous diseases
por: Satoh, Hiroaki, et al.
Publicado: (2023)

VATS and Intrapleural Fibrinolytic Therapy for Parapneumonic Empyema
por: Ohara, Gen, et al.
Publicado: (2018)

A population-based study of outcomes in patients with surgically resected non-small cell lung cancer with anaplastic lymphoma kinase-rearranged mutations: A matched-pair study
por: Inagaki, Masaharu, et al.
Publicado: (2021)

Prognostic factors for recurrence in patients with surgically resected non-small cell lung cancer
por: Moskalenko, Yuliia, et al.
Publicado: (2022)

Nivolumab and ipilimumab therapy in a patient with non-small cell lung cancer with chronic kidney disease
por: Satoh, Hiroaki, et al.
Publicado: (2022)

A long-term responding epidermal growth factor receptor mutated non-small cell lung cancer patient with extremely high mutation allele frequency
por: Miyazaki, Kunihiko, et al.
Publicado: (2022)

Characteristics of surgically resected non‐small cell lung cancer patients with post‐recurrence cure
por: Sonoda, Dai, et al.
Publicado: (2020)

Reply: K-Ras: a prognostic factor for survival in non-small cell lung cancer
por: Mascaux, C
Publicado: (2006)

Prognostic factors of tumor recurrence in completely resected non-small cell lung cancer
por: Tantraworasin, Apichat, et al.
Publicado: (2013)

Surgical Resection or Radiofrequency Ablation for Small Hepatocellular Carcinoma
por: Feng, Qingbo, et al.
Publicado: (2022)

An extended modification of transmanubrial osteomuscular sparing approach: salvage resection for recurrent superior sulcus lung cancer after definitive chemoradiotherapy
por: Sakakura, Noriaki, et al.
Publicado: (2021)

Quantitative severity of pulmonary emphysema as a prognostic factor for recurrence in patients with surgically resected non‐small cell lung cancer
por: Lee, Seung Jun, et al.
Publicado: (2018)

Prognostic value of AKT isoforms in non-small cell lung adenocarcinoma
por: Khurana, Sahil, et al.
Publicado: (2023)

Microbiological spectrum of pneumonia in patients with lung cancer
por: Tamura, Tomohiro, et al.
Publicado: (2016)

Advanced lung cancer inflammation index predicts the outcomes of patients with non-metastatic gastric cancer after radical surgical resection
por: Huo, Chenyu, et al.
Publicado: (2023)

Novel microwave surgical instrument for use in various lung resection situations
por: Kamigaichi, Atsushi, et al.
Publicado: (2021)

Adjuvant chemotherapy or immunotherapy for completely resected stage IB non-small cell lung cancer: still a grey zone?
por: Lee, Kuan-Yu, et al.
Publicado: (2023)

Prognostic factors in patients with postoperative brain recurrence from completely resected non-small cell lung cancer
por: Kanou, Takashi, et al.
Publicado: (2015)

Pattern of bone metastasis in patients with nonsmall cell lung cancer
por: Miyazaki, Kunihiko, et al.
Publicado: (2018)

Prognostic Significance of MYH9 Expression in Resected Non-Small Cell Lung Cancer
por: Katono, Ken, et al.
Publicado: (2015)

Positive tumour CD47 expression is an independent prognostic factor for recurrence in resected non-small cell lung cancer
por: Xu, Yan, et al.
Publicado: (2020)

Development of artificial intelligence prognostic model for surgically resected non-small cell lung cancer
por: Kinoshita, Fumihiko, et al.
Publicado: (2023)

Construction of an integrated prognostic classifier model for predicting the efficacy of immune checkpoint inhibitor therapy in non‐small cell lung cancer
por: Lin, Zhihuan, et al.
Publicado: (2020)

Quantitative definitions of prognostic indicators of resectable pancreatic cancer
por: Sun, Hang, et al.
Publicado: (2022)

Poor Prognostic Factors in Surgically Resected Stage I Non-small Cell Lung Cancer: Histopathologic and Immunohistochemical Analysis
por: Cho, Sukki, et al.
Publicado: (2012)

Relationship between obstructive lung disease and non-small cell lung cancer
por: Akamine, Takaki, et al.
Publicado: (2020)

Comment on ‘Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lung’
por: Ponzetto, Antonio, et al.
Publicado: (2017)

Treatment failure patterns of adjuvant gefitinib therapy and minimal residual disease detection in resected EGFR-mutant non-small cell lung cancer: author’s reply
por: Xu, Song-Tao, et al.
Publicado: (2020)

Recovery from paraplegia with administration of erlotinib in a patient with lung adenocarcinoma
por: Kurishima, Koichi, et al.
Publicado: (2014)

Clinicopathological Factors Related to Recurrence Patterns of Resected Non-Small Cell Lung Cancer
por: Shimizu, Reiko, et al.
Publicado: (2020)

Molecular risk factors for locoregional recurrence in resected non‐small cell lung cancer
por: Guo, Wei, et al.
Publicado: (2023)

Surgical resection for liver cancer during the COVID-19 outbreak
por: Triki, Haitham, et al.
Publicado: (2020)

Recurrent volvulus of the transverse colon after sigmoid resection
por: Booij, K. A. C., et al.
Publicado: (2008)

Merkel cell polyomavirus and non-small cell lung cancer
por: Shuda, M, et al.
Publicado: (2013)

Reply to: Comment on ‘Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lung’
por: Robinson, Lary A, et al.
Publicado: (2017)

Iterative surgical resections in non-small cell lung cancer
por: Ucvet, Ahmet, et al.
Publicado: (2022)

Prognostic significance of CpG island methylator phenotype in surgically resected small cell lung carcinoma
por: Saito, Yuichi, et al.
Publicado: (2016)

Prognostic implications of prostaglandin E-major urinary metabolite in resected non-small-cell lung cancer
por: Mikubo, Masashi, et al.
Publicado: (2023)

The prognostic factors of resected non-small cell lung cancer with chest wall invasion
por: Lee, Chang Young, et al.
Publicado: (2012)

Response to Afatinib in a Common EGFR-Mutated Lung Adenocarcinoma with a Very Rare Combination of Compound Mutations
por: Satoh, Hiroaki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jhallmln4a4lima972mclvgo3v